Medical News

RSS

Houston Methodist researchers receive CPRIT funding to research two of the most lethal cancers

Two Houston Methodist cancer researchers have been awarded a half million dollars in funding from the Cancer Prevention and Research Institute of Texas to further research two of the most lethal, difficult-to-treat cancers that all-too-often have poor prognoses.

28 Sep 2022

Montana health officials aim to boost oversight of nonprofit hospitals’ giving

Montana health officials are proposing to oversee and set standards for the charitable contributions that nonprofit hospitals make in their communities each year to justify their access to millions of dollars in tax exemptions.

28 Sep 2022

$2,700 ambulance bill pulled back from collections

Peggy Dula is as surprised as she is relieved. The 55-year-old resident of St. Charles, Illinois, had been fighting a $2,700 ambulance bill for nearly a year.

28 Sep 2022

COVID-19 cases, hospitalizations, and fatalities prevented by SARS-CoV-2 vaccination within the first 6 months after the vaccine became available

Researchers assessed the effect of SARS-CoV-2 vaccination in the US.

28 Sep 2022

mRNA boosters associated with decreased odds of hospitalization compared with the mRNA vaccine primary series alone

Researchers assessed the chances of COVID-19 hospitalization after three versus two mRNA vaccine doses.

28 Sep 2022

Researchers computationally design immunogens to elicit antibodies against different SARS-CoV-2 variants

A recent study designed immunogens to induce antibodies against SARS-CoV-2 variants.

28 Sep 2022

Can the gut be an alternative route for SARS-CoV-2 entry?

Researchers reviewed the gut pathophysiology of SARS-CoV-2 infection.

28 Sep 2022

Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19

Researchers evaluated the efficacy of the anti-inflammatory drug dimethyl fumarate in treating COVID-19 as part of an early phase, randomized, controlled assessment trial in the UK.

28 Sep 2022

Q-LAAD: a dynamic, cost-effective rapid antigen test for detection of SARS-CoV-2

Researchers developed a high-throughput, rapid antigen SARS-CoV-2 spike protein detection test using allonamers, a new type of aptamers that carry out allosteric regulation instead of catalytic activity.

28 Sep 2022

Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse

Actylis Integrates Aceto and its 10 Acquired Specialists with Broad Expertise in GMP and Non-GMP Raw Material Manufacturing and Sourcing into a Singular Global Brand

From Actylis 28 Sep 2022

Researchers to use $1 million grant for improving blood cancer diagnosis and treatment

Adelaide researchers will use a $1 million grant to improve the diagnosis and treatment of blood cancers, which kill 16 Australians every day.

28 Sep 2022

Wearable devices show promise in identifying early population changes in COVID-19 activity

Today, viral illnesses like COVID-19 are tracked using multiple different methods, including lab data, health care visits and wastewater surveillance.

28 Sep 2022

Wastewater epidemiology can guide local clinical decisions on circulating viruses

The findings of a new study posted to the medRxiv* preprint server depicted that wastewater-based epidemiology (WBE) can provide information on the circulating respiratory viruses in a community. As well as saving time and money, this method may assist in appropriate clinical decision-making, behavior modification, and public health interventions.

28 Sep 2022

UniSA’s new degree program to bolster midwifery workforce and support rural communities

Expectant mothers in South Australia’s Eyre Peninsula and northern regions will benefit from greater access to specialist midwifery care, as the University of South Australia introduces the Bachelor of Midwifery at its Whyalla campus from 2023.

28 Sep 2022

One-time test predicts which hospitalized COVID-19 patients are likely to worsen, study finds

A one-time test could predict which people hospitalized with COVID-19 are likely to worsen significantly during their stay, even if they were admitted with relatively mild symptoms, according to a study of more than 2,500 people headed by researchers at Stanford Medicine.

27 Sep 2022

Food, vaccines, bacteria, and viruses may all prime our immune system to attack SARS-CoV-2

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, primarily causes mild to moderate upper-respiratory tract illness. However, some individuals with COVID-19 develop severe infections and require hospital admission.

27 Sep 2022

Stanford Medicine scientists receive $10 million for research on sleep and autism

A group of Stanford Medicine scientists have been awarded approximately $10 million from the National Institutes of Health's Autism Centers of Excellence program.

27 Sep 2022

Bile acids play an important role in regulating gut microbiome

Scientists performe in vitro and in vivo experiments to investigate the antimicrobial effects of different bile acids on various microorganisms.

27 Sep 2022

Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma

A clinical trial led by clinicians at Georgetown Lombardi Comprehensive Cancer Center showed a remarkable 20 percent advantage in the two-year overall survival rate for people with advanced melanoma who first received immunotherapy (72 percent survival rate) versus those who initially got targeted therapies (52 percent survival rate).

27 Sep 2022

How the gut microbiome could affect COVID-19 severity

Researchers review the potential role of the gut microbiome in determining severe COVID-19.

27 Sep 2022

Medical News

Houston Methodist researchers receive CPRIT funding to research two of the most lethal cancers

Montana health officials aim to boost oversight of nonprofit hospitals’ giving

$2,700 ambulance bill pulled back from collections

COVID-19 cases, hospitalizations, and fatalities prevented by SARS-CoV-2 vaccination within the first 6 months after the vaccine became available

mRNA boosters associated with decreased odds of hospitalization compared with the mRNA vaccine primary series alone

Researchers computationally design immunogens to elicit antibodies against different SARS-CoV-2 variants

Can the gut be an alternative route for SARS-CoV-2 entry?

Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19

Q-LAAD: a dynamic, cost-effective rapid antigen test for detection of SARS-CoV-2

Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse

Researchers to use $1 million grant for improving blood cancer diagnosis and treatment

Wearable devices show promise in identifying early population changes in COVID-19 activity

Wastewater epidemiology can guide local clinical decisions on circulating viruses

UniSA’s new degree program to bolster midwifery workforce and support rural communities

One-time test predicts which hospitalized COVID-19 patients are likely to worsen, study finds

Food, vaccines, bacteria, and viruses may all prime our immune system to attack SARS-CoV-2

Stanford Medicine scientists receive $10 million for research on sleep and autism

Bile acids play an important role in regulating gut microbiome

Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma

How the gut microbiome could affect COVID-19 severity

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News